We are experienced in virtually all classes of compounds and offer capabilities in the performance of studies to support the safety evaluation of drugs, biologics, proteins, peptides, gene therapy compounds, monoclonal antibodies, and other chemicals, as well as devices from not only the discovery phase, but through the preclinical phase to IND submissions, including the first-into-man studies. Calvert also performs studies to support NDA submissions.
Outsourcing-Pharma.com
Accenture & ICRI partner for Indian clinical research training
2 Sep 2010 | 5:00 am EDT
Quintiles lands CF drug commercialisation contract
2 Sep 2010 | 5:00 am EDT
BNC says nano approach can aid drug-target research
2 Sep 2010 | 5:00 am EDT
Toxicology News
Prenatal pesticides exposure linked to disorders
19 Aug 2010 | 11:08 pm EDT
ORAU: No harm to health detected from fly ash
18 Aug 2010 | 6:53 pm EDT
Agilent Technologies and Johns Hopkins University to Research Novel...
18 Aug 2010 | 2:44 pm EDT
Pharmacology News
Cetero Research Launches Seminar Series On Accelerated...
3 Sep 2010 | 3:22 am EDT
Colleges
2 Sep 2010 | 3:53 pm EDT
Functional crosstalk between GPCRs: with or without oligomerization.
2 Sep 2010 | 7:23 am EDT
Immunology News
Advanced Photon Source helps answer key questions about common cold virus
3 Sep 2010 | 3:32 am EDT
Interleukin-33 Induces Protective Effects in Adipose Tissue...
3 Sep 2010 | 2:28 am EDT
Specialist: Food allergies should not stop a child's social life
2 Sep 2010 | 10:18 pm EDT
